Tazarotene, 0.045% Lotion, improves Acne and Skin Oiliness in Patients with Oily Skin


eMediNexus    06 January 2023

Excessive sebum production triggers acne development. Tazarotene, 0.045% lotion, reduces acne lesions and acne-induced sequelae.


A recent study evaluated the efficacy, changes in skin oiliness, and safety of tazarotene 0.045% lotion in participants with moderate-to-severe acne and oily skin.


This two-phase 3, double-blind, 12-week study included participants aged ≥9 years with moderate-to-severe acne and randomized them 1:1 to once-daily tazarotene 0.045% lotion or vehicle lotion. It evaluated inflammatory/noninflammatory lesion counts, treatment success, skin oiliness, treatment-emergent adverse events (TEAEs), and cutaneous safety/tolerability.


The study observed-


  • Tazarotene provided greater reductions in inflammatory/noninflammatory lesions and greater treatment success rates versus vehicle in all participants with oily skin at week 12.
  • More than two-thirds of polymeric lotion-treated participants showed subjective skin oiliness reductions by week 12, with nearly one-third reporting low/not oily skin.
  • Tazarotene TEAE rates showed similarity to the overall population.


This study shows that once-daily treatment with tazarotene 0.045% polymeric emulsion lotion improves patient-perceived skin oiliness in those with moderate-to-severe acne.


Tanghetti EA, Zeichner JA, Gold M, et al., Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Patients with Oily Skin. Journal of Dermatological Treatment. 2022. DOI: 10.1080/09546634.2022.2147391

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.